+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Flourishing Medical Tourism Industry in Asia to Drive Increased Demand for Preimplantation Genetic Diagnosis, says TMR

Posted on Mar 28, 2016

The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region.

However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that the rising preference to assisted reproductive techniques and flourishing medical tourism industry will help the Asia PGD market gain sustained business in the near future.



Rising Preference for Assisted Reproductive Techniques to be Key Enabler of PGD Market in Asia

Rising preference to assisted reproductive techniques, which involve preimplantation genetic diagnosis as a standard course of action for ensuring that the embryo is free of any genetic anomalies, is central to the healthy growth of the Asia PGD market. The demand for assisted reproductive techniques in the region is driven majorly due to two factors: delayed age of conception among women and the alarmingly rising rate of infertility in the region.

With rising participation in the region’s workforce, a significant number of Asian women are conceiving their babies in late 20s to late 30s. As infertility issues and challenges concerned with conceiving start intensifying as the age rises, couples in the region are increasingly preferring assisted reproductive techniques such as in vitro fertilization.

Rate of infertility in countries such as China and India has substantially increased in the past few years. Xinhua, one of China’s prominent news agencies has stated that around 12.5% of China’s population was infertile in 2010. In India too, around 10% of the population was said to be suffering from infertility in 2013. Considering the total population of over 2.5 bn of these two countries, the number of infertile people in these countries is massive. Thus, the potential for rise in numbers of assisted reproductive techniques and, correspondingly, in the number of PGD tests is massive in Asia.

Southern Asia to Provide Most Attractive Growth Opportunities

Owing to the controversial nature of PGD techniques, they are not offered at all healthcare centers and are banned in entirety or are limited to the scanning of some specific genetic traits only. In most Asian countries where PGD is not prohibited, it is controlled by the regional or national government. The high costs of PGD techniques are also an area of immense concern for certain cost sensitive countries in the region. Combined with liberal regulatory norms and the rising population of high-earning individuals, Southern Asia will emerge as the most lucrative market for preimplantation genetic diagnosis in the next few years.

The PGD market in Southern Asia is expected to rise at a favorable 7.9% CAGR from 2015 to 2023. During the same period, the market for PGD in Central and Western Asia is expected to witness sluggish development owing to lower penetration of advanced technologies in the healthcare industries and stringent guidelines related to PGD tests in the regions.

As a whole, the Asia preimplantation genetic diagnosis market, which had a valuation of US$16.0 mn in 2014, will exhibit a CAGR of 6.8% from 2015 to 2023, and rise to US$28.8 mn by 2023.

This review of the market is based on a recent market research report published by Transparency Market Research, titled “Preimplantation Genetic Diagnosis Market - Asia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.”

For the purpose of this study, the market has been segmented into:

Asia Preimplantation Genetic Diagnosis (PGD) Market, by Test Type

  • PGD for Aneuploidy Screening
  • PGD for Chromosomal Aberrations
  • PGD for Gender Selection
  • PGD for HLA Typing
  • PGD for Single Gene Disorder
  • PGD for X-linked diseases

Asia Preimplantation Genetic Diagnosis (PGD) Market, by End-user

  • Fertility Clinics
  • Health Care Facilities (including hospitals, diagnostic centers, and health care facilities)
  • Academic Institutes and Research Centers

Asia Preimplantation Genetic Diagnosis (PGD) Market, by Geography

  • South Eastern Asia
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Rest of SEA
  • Eastern Asia
    • China
    • Japan
    • South Korea
    • Rest of Eastern Asia
  • Southern Asia
    • India
    • Sri Lanka
    • Rest of Southern Asia
  • Central Asia
  • Western Asia
    • Israel
    • Turkey
    • Jordan
    • Saudi Arabia
    • United Arab Emirates
    • Rest of Western Asia

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top